Abstract
A series of novel RGD mimetics containing phthalimidine fragment was designed and synthesized. Their antiaggregative activity determined by Born's method was shown to be due to inhibition of fibrinogen binding to αIIbβ₃. Molecular docking of RGD mimetics to αIIbβ₃ receptor showed the key interactions in this complex, and also some correlations have been observed between values of biological activity and docking scores. The single crystal X-ray data were obtained for five mimetics.
Copyright © 2013 The Authors. Published by Elsevier Ltd.. All rights reserved.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Binding Sites
-
Biomimetic Materials / chemistry*
-
Biomimetic Materials / metabolism
-
Biomimetic Materials / pharmacology
-
Crystallography, X-Ray
-
Fibrinogen / antagonists & inhibitors
-
Fibrinogen / metabolism
-
Humans
-
Isoindoles / chemistry*
-
Isoindoles / metabolism
-
Isoindoles / pharmacology
-
Ligands
-
Models, Molecular
-
Molecular Docking Simulation
-
Molecular Structure
-
Oligopeptides / chemistry*
-
Oligopeptides / metabolism
-
Oligopeptides / pharmacology
-
Phthalimides / chemistry*
-
Phthalimides / metabolism
-
Phthalimides / pharmacology
-
Platelet Aggregation / drug effects
-
Platelet Glycoprotein GPIIb-IIIa Complex / antagonists & inhibitors
-
Platelet Glycoprotein GPIIb-IIIa Complex / chemistry*
-
Platelet Glycoprotein GPIIb-IIIa Complex / metabolism
-
Protein Binding
Substances
-
Isoindol-1-one
-
Isoindoles
-
Ligands
-
Oligopeptides
-
Phthalimides
-
Platelet Glycoprotein GPIIb-IIIa Complex
-
phthalimidine
-
arginyl-glycyl-aspartic acid
-
Fibrinogen